Cargando…

Views of policymakers, healthcare workers and NGOs on HIV pre-exposure prophylaxis (PrEP): a multinational qualitative study

OBJECTIVES: To examine policymakers and providers' views on pre-exposure prophylaxis (PrEP) and their willingness to support its introduction, to inform policy and practice in this emerging field. DESIGN: Semistructured qualitative interview study. SETTING: Peru, Ukraine, India, Kenya, Uganda,...

Descripción completa

Detalles Bibliográficos
Autores principales: Wheelock, Ana, Eisingerich, Andreas B, Gomez, Gabriela B, Gray, Emily, Dybul, Mark R, Piot, Peter
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Group 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3391366/
https://www.ncbi.nlm.nih.gov/pubmed/22761288
http://dx.doi.org/10.1136/bmjopen-2012-001234
_version_ 1782237517525811200
author Wheelock, Ana
Eisingerich, Andreas B
Gomez, Gabriela B
Gray, Emily
Dybul, Mark R
Piot, Peter
author_facet Wheelock, Ana
Eisingerich, Andreas B
Gomez, Gabriela B
Gray, Emily
Dybul, Mark R
Piot, Peter
author_sort Wheelock, Ana
collection PubMed
description OBJECTIVES: To examine policymakers and providers' views on pre-exposure prophylaxis (PrEP) and their willingness to support its introduction, to inform policy and practice in this emerging field. DESIGN: Semistructured qualitative interview study. SETTING: Peru, Ukraine, India, Kenya, Uganda, Botswana and South Africa. PARTICIPANTS: 35 policymakers, 35 healthcare workers and 21 non-governmental organisation representatives involved in HIV prevention. RESULTS: Six themes emerged from the data: (1) perceived HIV prevention landscape: prevention initiatives needed to be improved and expanded; (2) PrEP awareness: 50 of 91 participants had heard of PrEP; (3) benefits of PrEP: one component of the combination prevention arsenal that could help prioritise HIV prevention, empower key populations and result in economic gains; (4) challenges of PrEP: regimen complexity, cost and cost-effectiveness, risk compensation, efficacy and effectiveness, stigmatisation and criminalisation, information and training and healthcare system capacity; (5) programmatic considerations: user eligibility, communication strategy, cost, distribution, medication and HIV testing compliance and (6) early versus late implementation: participants were divided as to whether they would support an early introduction of PrEP in their country or would prefer to wait until it has been successfully implemented in other countries, with around half of those we spoke to supporting each option. Very few said they would not support PrEP at all. CONCLUSIONS: Despite the multiple challenges identified, there was general willingness to support the introduction of PrEP. Yet, strengthening existing HIV prevention efforts was also deemed necessary. Our results suggest that an effective PrEP programme would be delivered in healthcare facilities and involve non-governmental organisations and the community and consider the needs of mobile populations. Comprehensive information packages and training for users and providers would be critical. The cost of PrEP would be affordable and possibly segmented. Extensive counselling and innovative monitoring measures ought to be considered.
format Online
Article
Text
id pubmed-3391366
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher BMJ Group
record_format MEDLINE/PubMed
spelling pubmed-33913662012-07-10 Views of policymakers, healthcare workers and NGOs on HIV pre-exposure prophylaxis (PrEP): a multinational qualitative study Wheelock, Ana Eisingerich, Andreas B Gomez, Gabriela B Gray, Emily Dybul, Mark R Piot, Peter BMJ Open Infectious Diseases OBJECTIVES: To examine policymakers and providers' views on pre-exposure prophylaxis (PrEP) and their willingness to support its introduction, to inform policy and practice in this emerging field. DESIGN: Semistructured qualitative interview study. SETTING: Peru, Ukraine, India, Kenya, Uganda, Botswana and South Africa. PARTICIPANTS: 35 policymakers, 35 healthcare workers and 21 non-governmental organisation representatives involved in HIV prevention. RESULTS: Six themes emerged from the data: (1) perceived HIV prevention landscape: prevention initiatives needed to be improved and expanded; (2) PrEP awareness: 50 of 91 participants had heard of PrEP; (3) benefits of PrEP: one component of the combination prevention arsenal that could help prioritise HIV prevention, empower key populations and result in economic gains; (4) challenges of PrEP: regimen complexity, cost and cost-effectiveness, risk compensation, efficacy and effectiveness, stigmatisation and criminalisation, information and training and healthcare system capacity; (5) programmatic considerations: user eligibility, communication strategy, cost, distribution, medication and HIV testing compliance and (6) early versus late implementation: participants were divided as to whether they would support an early introduction of PrEP in their country or would prefer to wait until it has been successfully implemented in other countries, with around half of those we spoke to supporting each option. Very few said they would not support PrEP at all. CONCLUSIONS: Despite the multiple challenges identified, there was general willingness to support the introduction of PrEP. Yet, strengthening existing HIV prevention efforts was also deemed necessary. Our results suggest that an effective PrEP programme would be delivered in healthcare facilities and involve non-governmental organisations and the community and consider the needs of mobile populations. Comprehensive information packages and training for users and providers would be critical. The cost of PrEP would be affordable and possibly segmented. Extensive counselling and innovative monitoring measures ought to be considered. BMJ Group 2012-07-02 /pmc/articles/PMC3391366/ /pubmed/22761288 http://dx.doi.org/10.1136/bmjopen-2012-001234 Text en © 2012, Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions. This is an open-access article distributed under the terms of the Creative Commons Attribution Non-commercial License, which permits use, distribution, and reproduction in any medium, provided the original work is properly cited, the use is non commercial and is otherwise in compliance with the license. See: http://creativecommons.org/licenses/by-nc/2.0/ and http://creativecommons.org/licenses/by-nc/2.0/legalcode.
spellingShingle Infectious Diseases
Wheelock, Ana
Eisingerich, Andreas B
Gomez, Gabriela B
Gray, Emily
Dybul, Mark R
Piot, Peter
Views of policymakers, healthcare workers and NGOs on HIV pre-exposure prophylaxis (PrEP): a multinational qualitative study
title Views of policymakers, healthcare workers and NGOs on HIV pre-exposure prophylaxis (PrEP): a multinational qualitative study
title_full Views of policymakers, healthcare workers and NGOs on HIV pre-exposure prophylaxis (PrEP): a multinational qualitative study
title_fullStr Views of policymakers, healthcare workers and NGOs on HIV pre-exposure prophylaxis (PrEP): a multinational qualitative study
title_full_unstemmed Views of policymakers, healthcare workers and NGOs on HIV pre-exposure prophylaxis (PrEP): a multinational qualitative study
title_short Views of policymakers, healthcare workers and NGOs on HIV pre-exposure prophylaxis (PrEP): a multinational qualitative study
title_sort views of policymakers, healthcare workers and ngos on hiv pre-exposure prophylaxis (prep): a multinational qualitative study
topic Infectious Diseases
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3391366/
https://www.ncbi.nlm.nih.gov/pubmed/22761288
http://dx.doi.org/10.1136/bmjopen-2012-001234
work_keys_str_mv AT wheelockana viewsofpolicymakershealthcareworkersandngosonhivpreexposureprophylaxisprepamultinationalqualitativestudy
AT eisingerichandreasb viewsofpolicymakershealthcareworkersandngosonhivpreexposureprophylaxisprepamultinationalqualitativestudy
AT gomezgabrielab viewsofpolicymakershealthcareworkersandngosonhivpreexposureprophylaxisprepamultinationalqualitativestudy
AT grayemily viewsofpolicymakershealthcareworkersandngosonhivpreexposureprophylaxisprepamultinationalqualitativestudy
AT dybulmarkr viewsofpolicymakershealthcareworkersandngosonhivpreexposureprophylaxisprepamultinationalqualitativestudy
AT piotpeter viewsofpolicymakershealthcareworkersandngosonhivpreexposureprophylaxisprepamultinationalqualitativestudy